IFG Advisory’s Virtus Biotech ETF BBP Stock Holding History

IFG Advisory’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$237K	Buy	+2,245	New	+$229K	0.01%	828

Other funds holding BBP

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

WBI Investments Red Bank, New Jersey $384M AUM 34.15% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Advisor Resource Council Dallas, Texas $296M AUM 24.5% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Axos Invest Las Vegas, Nevada $133M AUM 11.38% 1-Year Est. Return

IFG Advisory's BBP Position: Q3 2026 in Review

IFG Advisory opened a new position in Virtus Biotech ETF (BBP) in Q3 2026: 2,245 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #828 among its holdings.

17 funds tracked by Wall St. Rank hold BBP as of Q3 2026.

IFG Advisory held 2,245 shares of Virtus Biotech ETF worth $237K as of Q3 2026.
Virtus Biotech ETF was a new IFG Advisory position in Q3 2026.
Virtus Biotech ETF made up 0.01% of IFG Advisory's portfolio in Q3 2026, its #828 holding.
17 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2026.

Based on IFG Advisory's 13F filing for Q3 2026, filed 9 Nov 2026.